Please join me in congratulating Dr. Logothetis for receiving a $3M RO1 grant from NIH!
The “Structural determinants of PIP2 regulation” is an NIH Heart, Lung, and Blood Institute (NHLBI) grant that was initiated in 1998 by Diomedes Logothetis and was just renewed for a 6th consecutive cycle for years 23 through 26. This ...more
Tali Konry wants to design a more effective serial killer.
That may sound a little sketchy until you learn that Konry’s serial killers are immune cells, and their target is cancer.
Konry, a professor of pharmaceutical sciences, is developing a technology that will address one of the most daunting challenges in cellular immunotherapy: the low success rates ...more
For decades, scientists have searched for a synthetic alternative to medical marijuana that can deliver its medicinal benefits without the harmful side effects. The problem is that the positives and negatives are tied together at the molecular level, and no one has found a way to separate them.
Like a determined prospector, pharmacy professor Ganesh Thakur ...more
By Bill Ibelle, Editorial Director
One of the biggest challenges in our nation’s escalating opioid epidemic is the high risk of relapse.
Barbara Waszczak, Professor, School of Pharmacy
Nearly 60 percent of the opioid users who seek treatment use the drug again, according to the National Institute on Drug Abuse. This is due, at least in part, to ...more
September 4, 2018
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.